Cargando…

Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer

MicroRNAs (miRNAs) are small non-coding RNAs that function as post-transcriptional regulators of gene expression and are dysregulated in cancer. Studies of miRNAs to explore their potential as diagnostic and prognostic markers are of great scientific interest. Here, we investigate the functional pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Johannessen, Charles, Moi, Line, Kiselev, Yury, Pedersen, Mona Irene, Dalen, Stig Manfred, Braaten, Tonje, Busund, Lill-Tove
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657998/
https://www.ncbi.nlm.nih.gov/pubmed/29073169
http://dx.doi.org/10.1371/journal.pone.0186658
_version_ 1783273921386119168
author Johannessen, Charles
Moi, Line
Kiselev, Yury
Pedersen, Mona Irene
Dalen, Stig Manfred
Braaten, Tonje
Busund, Lill-Tove
author_facet Johannessen, Charles
Moi, Line
Kiselev, Yury
Pedersen, Mona Irene
Dalen, Stig Manfred
Braaten, Tonje
Busund, Lill-Tove
author_sort Johannessen, Charles
collection PubMed
description MicroRNAs (miRNAs) are small non-coding RNAs that function as post-transcriptional regulators of gene expression and are dysregulated in cancer. Studies of miRNAs to explore their potential as diagnostic and prognostic markers are of great scientific interest. Here, we investigate the functional properties and expression of the miR-143/145 cluster in breast cancer (BC) in vitro and in vivo. The ER positive MCF7, the HER2 positive SK-BR-3, and the triple negative cell line MDA-MB-231 were used to assess cell proliferation and cell invasion. Expression of miRNA in 108 breast cancers in the Norwegian Women and Cancer Study and 44 benign tissue controls were analyzed by microarray and validated by RT-PCR. Further, in situ hybridization (ISH) was used to study the cellular and subcellular distribution of the miRNAs. In vitro, miR-143 promoted proliferation of MCF7 and MDA-MB-231 cells, whereas miR-145 and the cotransfection of both miRNAs inhibited proliferation in all three cell lines. The cells’ invasive capacity was reduced after transfection and cotransfection of the miRNAs. In line with the tumor suppressive functions in vitro, the expression of miR-143 and miR-145 was lower in malignant compared to benign breast tissue, and lower in the more aggressive tumors with higher tumor grade, loss of ER and the basal-like phenotype. ISH revealed miR-143 to be cytoplasmatic and predominantly expressed in luminal cells in benign tissue, whilst miR-145 was nuclear and with strong staining in myoepithelial cells. Both miRNAs were present in malignant epithelial cells and stromal fibroblasts in BC. This study demonstrates that miR-143 and -145 have functional properties and expression patterns typical for tumor suppressors, but the function is influenced by cellular factors such as cell type and miRNA cotransfection. Further, the nuclear functions of miR-145 should be explored for a more complete understanding of the complexity of miRNA regulation and function in BC.
format Online
Article
Text
id pubmed-5657998
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56579982017-11-09 Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer Johannessen, Charles Moi, Line Kiselev, Yury Pedersen, Mona Irene Dalen, Stig Manfred Braaten, Tonje Busund, Lill-Tove PLoS One Research Article MicroRNAs (miRNAs) are small non-coding RNAs that function as post-transcriptional regulators of gene expression and are dysregulated in cancer. Studies of miRNAs to explore their potential as diagnostic and prognostic markers are of great scientific interest. Here, we investigate the functional properties and expression of the miR-143/145 cluster in breast cancer (BC) in vitro and in vivo. The ER positive MCF7, the HER2 positive SK-BR-3, and the triple negative cell line MDA-MB-231 were used to assess cell proliferation and cell invasion. Expression of miRNA in 108 breast cancers in the Norwegian Women and Cancer Study and 44 benign tissue controls were analyzed by microarray and validated by RT-PCR. Further, in situ hybridization (ISH) was used to study the cellular and subcellular distribution of the miRNAs. In vitro, miR-143 promoted proliferation of MCF7 and MDA-MB-231 cells, whereas miR-145 and the cotransfection of both miRNAs inhibited proliferation in all three cell lines. The cells’ invasive capacity was reduced after transfection and cotransfection of the miRNAs. In line with the tumor suppressive functions in vitro, the expression of miR-143 and miR-145 was lower in malignant compared to benign breast tissue, and lower in the more aggressive tumors with higher tumor grade, loss of ER and the basal-like phenotype. ISH revealed miR-143 to be cytoplasmatic and predominantly expressed in luminal cells in benign tissue, whilst miR-145 was nuclear and with strong staining in myoepithelial cells. Both miRNAs were present in malignant epithelial cells and stromal fibroblasts in BC. This study demonstrates that miR-143 and -145 have functional properties and expression patterns typical for tumor suppressors, but the function is influenced by cellular factors such as cell type and miRNA cotransfection. Further, the nuclear functions of miR-145 should be explored for a more complete understanding of the complexity of miRNA regulation and function in BC. Public Library of Science 2017-10-26 /pmc/articles/PMC5657998/ /pubmed/29073169 http://dx.doi.org/10.1371/journal.pone.0186658 Text en © 2017 Johannessen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Johannessen, Charles
Moi, Line
Kiselev, Yury
Pedersen, Mona Irene
Dalen, Stig Manfred
Braaten, Tonje
Busund, Lill-Tove
Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
title Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
title_full Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
title_fullStr Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
title_full_unstemmed Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
title_short Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
title_sort expression and function of the mir-143/145 cluster in vitro and in vivo in human breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657998/
https://www.ncbi.nlm.nih.gov/pubmed/29073169
http://dx.doi.org/10.1371/journal.pone.0186658
work_keys_str_mv AT johannessencharles expressionandfunctionofthemir143145clusterinvitroandinvivoinhumanbreastcancer
AT moiline expressionandfunctionofthemir143145clusterinvitroandinvivoinhumanbreastcancer
AT kiselevyury expressionandfunctionofthemir143145clusterinvitroandinvivoinhumanbreastcancer
AT pedersenmonairene expressionandfunctionofthemir143145clusterinvitroandinvivoinhumanbreastcancer
AT dalenstigmanfred expressionandfunctionofthemir143145clusterinvitroandinvivoinhumanbreastcancer
AT braatentonje expressionandfunctionofthemir143145clusterinvitroandinvivoinhumanbreastcancer
AT busundlilltove expressionandfunctionofthemir143145clusterinvitroandinvivoinhumanbreastcancer